A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas

Clinical trial NCT00036569 · COMPLETED

Trial details

NCT number: NCT00036569
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma

Start date: 2002-05-01
Primary completion: 2010-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.